MRI IS AN IMAGING BIOMARKER TO DIAGNOSE STEATOTIC HCC SUSCEPTIBLE TO COMBINATION IMMUNOTHERAPY FOR ADVANCED HCC PATIENTS.

Murai, H; Kodama, T; Maesaka, K; Hikita, H; Sakamori, R; Tatsumi, T; Takehara, T

HEPATOLOGY, 2022; 76 (): S170

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索